These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

962 related items for PubMed ID: 16765178

  • 1. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O.
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
    Boorjian S, Ng C, Munver R, Palese MA, Vaughan ED, Sosa RE, Del Pizzo JJ, Scherr DS.
    Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
    [Abstract] [Full Text] [Related]

  • 4. Endoscopic treatment of upper tract transitional cell carcinoma.
    Soderdahl DW, Fabrizio MD, Rahman NU, Jarrett TW, Bagley DH.
    Urol Oncol; 2005 Aug; 23(2):114-22. PubMed ID: 15869996
    [Abstract] [Full Text] [Related]

  • 5. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.
    Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, Cussenot O.
    Eur Urol; 2007 Mar; 51(3):709-13; discussion 714. PubMed ID: 16911852
    [Abstract] [Full Text] [Related]

  • 6. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH.
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, England RC, Lemberger RJ.
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [Abstract] [Full Text] [Related]

  • 11. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML.
    BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M.
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
    Taweemonkongsap T, Nualyong C, Amornvesukit T, Leewansangtong S, Srinualnad S, Chaiyaprasithi B, Sujijantararat P, Tantiwong A, Soontrapa S.
    World J Surg Oncol; 2008 Jan 15; 6():3. PubMed ID: 18194580
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
    Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS.
    J Urol; 2010 Jun 15; 183(6):2148-53. PubMed ID: 20399468
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC, Mahendra V, Roberts JG.
    J Urol; 2003 Mar 15; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Manabe D, Saika T, Ebara S, Uehara S, Nagai A, Fujita R, Irie S, Yamada D, Tsushima T, Nasu Y, Kumon H, Okayama Urological Research Group, Okayama, Japan.
    Urology; 2007 Mar 15; 69(3):457-61. PubMed ID: 17382144
    [Abstract] [Full Text] [Related]

  • 17. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M, Remzi M, Klingler HC, Mueller L, Marberger M.
    BJU Int; 2009 Jan 15; 103(1):66-70. PubMed ID: 18710438
    [Abstract] [Full Text] [Related]

  • 18. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?
    Rassweiler JJ, Schulze M, Marrero R, Frede T, Palou Redorta J, Bassi P.
    Eur Urol; 2004 Dec 15; 46(6):690-7. PubMed ID: 15548434
    [Abstract] [Full Text] [Related]

  • 19. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.
    J Urol; 2007 May 15; 177(5):1721-6. PubMed ID: 17437796
    [Abstract] [Full Text] [Related]

  • 20. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb 15; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.